Agonistic or antagonistic mucosal-associated invariant T (MAIT) cell activity is determined by the 6-alkylamino substituent on uracil MR1 ligands

被引:10
|
作者
Braganza, Chriselle D. [1 ]
Motozono, Chihiro [2 ]
Sonoda, Koh-Hei [3 ]
Yamasaki, Sho [2 ,4 ,5 ,6 ]
Shibata, Kensuke [3 ,4 ,7 ]
Timmer, Mattie S. M. [1 ]
Stocker, Bridget L. [1 ]
机构
[1] Victoria Univ Wellington, Sch Chem & Phys Sci, POB 600, Wellington, New Zealand
[2] Osaka Univ, Res Inst Microbial Dis, Dept Mol Immunol, Osaka, Japan
[3] Kyushu Univ, Grad Sch Med Sci, Dept Ocular Pathol & Imaging Sci, Fukuoka, Japan
[4] Osaka Univ, Immunol Frontier Res Ctr, Lab Mol Immunol, Suita, Osaka 5650871, Japan
[5] Kyushu Univ, Med Inst Bioregulat, Div Mol Immunol, Fukuoka 8128582, Japan
[6] Chiba Univ, Med Mycol Res Ctr, Div Mol Immunol, Chiba 2608673, Japan
[7] Yamaguchi Univ, Grad Sch Med, Syst Biochem Pathol & Regenerat, Ube, Yamaguchi, Japan
关键词
CHAIN;
D O I
10.1039/d0cc00247j
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Mucosal-associated invariant T (MAIT) are a subset of innate-like T cells that are activated by uracil ligands presented by MR1. For the first time, we demonstrate that changes to the 6-aminoalkyl chain on uracil agonist 5-OP-RU can determine agonistic or antagonistic MAIT cell activity. Insomuch, a simplified agonist with a functional profile similar to 5-OP-RU, and a new structural class of antagonist that exhibits similar activity to known MAIT cell antagonist Ac-6-FP, were identified.
引用
收藏
页码:5291 / 5294
页数:4
相关论文
共 31 条
  • [31] CXCR6-positive circulating mucosal-associated invariant T cells can identify patients with non-small cell lung cancer responding to anti-PD-1 immunotherapy
    Qu, Jingjing
    Wu, Binggen
    Chen, Lijun
    Wen, Zuoshi
    Fang, Liangjie
    Zheng, Jing
    Shen, Qian
    Heng, Jianfu
    Zhou, Jianya
    Zhou, Jianying
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)